Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock Payable [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Mar. 31, 2019 $ 5,300 $ 39,573 $ 50,006,919 $ 0 $ (38,694,879) $ 11,356,913
Beginning balance (in shares) at Mar. 31, 2019 5,300,000 39,573,512        
Common shares issued upon exercise of warrants   $ 1,774 1,178,712     1,180,486
Common shares issued upon exercise of warrants (in shares)   1,774,000        
Stock Option expense     1,103,740     1,103,740
Net (loss)         (5,056,188) (5,056,188)
Ending balance at Jun. 30, 2019 $ 5,300 $ 41,347 52,289,371 0 (43,751,067) 8,584,951
Ending balance (in shares) at Jun. 30, 2019 5,300,000 41,347,512        
Beginning balance at Mar. 31, 2019 $ 5,300 $ 39,573 50,006,919 0 (38,694,879) 11,356,913
Beginning balance (in shares) at Mar. 31, 2019 5,300,000 39,573,512        
Net (loss)           (10,842,818)
Ending balance at Dec. 31, 2019 $ 5,300 $ 43,685 53,932,243 0 (49,537,697) 4,443,531
Ending balance (in shares) at Dec. 31, 2019 5,300,000 43,685,592        
Beginning balance at Jun. 30, 2019 $ 5,300 $ 41,347 52,289,371 0 (43,751,067) 8,584,951
Beginning balance (in shares) at Jun. 30, 2019 5,300,000 41,347,512        
Common shares issued upon exercise of warrants   $ 2,200 1,317,800     1,320,000
Common shares issued upon exercise of warrants (in shares)   2,200,000        
Stock Option expense     162,605     162,605
Stock Option exercise   $ 138 (138)     0
Stock Option exercise (in shares)   138,080        
Net (loss)         (2,924,957) (2,924,957)
Ending balance at Sep. 30, 2019 $ 5,300 $ 43,685 53,769,638 0 (46,676,024) 7,142,599
Ending balance (in shares) at Sep. 30, 2019 5,300,000 43,685,592        
Stock Option expense     162,605     162,605
Net (loss)         (2,861,673) (2,861,673)
Ending balance at Dec. 31, 2019 $ 5,300 $ 43,685 53,932,243 0 (49,537,697) 4,443,531
Ending balance (in shares) at Dec. 31, 2019 5,300,000 43,685,592        
Beginning balance at Mar. 31, 2020 $ 3,400 $ 45,585 54,094,848 1,000,000 (53,521,700) 1,622,133
Beginning balance (in shares) at Mar. 31, 2020 3,400,000 45,585,592        
Preferred Stock Conversion $ (3,400) $ 3,400        
Preferred Stock Conversion (in shares) (3,400,000) 3,400,000        
Common shares issued in connection with offerings   $ 9,750 3,890,250 (1,000,000)   2,900,000
Common shares issued in connection with offerings (in shares)   9,750,000        
Common shares issued upon exercise of warrants   $ 288 258,612     258,900
Common shares issued upon exercise of warrants (in shares)   287,666        
Common shares issued to non-employees   $ 452 466,848     467,300
Common shares issued to non-employees (in shares)   452,000        
Common shares issued to employees   $ 20 19,980     20,000
Common shares issued to employees (in shares)   20,000        
Stock Option expense     661,959     661,959
Stock Option exercise   $ 116 61,364     61,480
Stock Option exercise (in shares)   116,000        
Stock Payable       1,999,998   1,999,998
Net (loss)         (3,021,003) (3,021,003)
Ending balance at Jun. 30, 2020 $ 0 $ 59,611 59,453,861 1,999,998 (56,542,703) 4,970,767
Ending balance (in shares) at Jun. 30, 2020 0 59,611,258        
Beginning balance at Mar. 31, 2020 $ 3,400 $ 45,585 54,094,848 1,000,000 (53,521,700) 1,622,133
Beginning balance (in shares) at Mar. 31, 2020 3,400,000 45,585,592        
Net (loss)           (11,742,965)
Ending balance at Dec. 31, 2020 $ 0 $ 73,637 67,010,711 0 (65,264,665) 1,819,683
Ending balance (in shares) at Dec. 31, 2020 0 73,637,115        
Beginning balance at Jun. 30, 2020 $ 0 $ 59,611 59,453,861 1,999,998 (56,542,703) 4,970,767
Beginning balance (in shares) at Jun. 30, 2020 0 59,611,258        
Common shares issued in connection with offerings   $ 4,444 1,995,554 (1,999,998)    
Common shares issued in connection with offerings (in shares)   4,444,440        
Common shares issued upon exercise of warrants   $ 8,839 4,555,484     4,564,323
Common shares issued upon exercise of warrants (in shares)   8,839,399        
Common shares issued to non-employees   $ 191 326,408     326,599
Common shares issued to non-employees (in shares)   191,136        
Stock Option expense     204,594     204,594
Stock Option exercise   $ 236 (236)      
Stock Option exercise (in shares)   236,239        
Net (loss)         (4,361,628) (4,361,628)
Ending balance at Sep. 30, 2020 $ 0 $ 73,321 66,535,665 0 (60,904,331) 5,704,655
Ending balance (in shares) at Sep. 30, 2020 0 73,322,472        
Common shares issued upon exercise of warrants   $ 167 91,498     91,665
Common shares issued upon exercise of warrants (in shares)   166,666        
Common shares issued to non-employees   $ 99 119,900     119,999
Common shares issued to non-employees (in shares)   97,977        
Common shares issued to employees   $ 50 49,950     50,000
Common shares issued to employees (in shares)   50,000        
Stock Option expense     213,698     213,698
Stock Option exercise           0
Net (loss)         (4,360,334) (4,360,334)
Ending balance at Dec. 31, 2020 $ 0 $ 73,637 $ 67,010,711 $ 0 $ (65,264,665) $ 1,819,683
Ending balance (in shares) at Dec. 31, 2020 0 73,637,115